Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 30, 2026

Study Completion Date

December 31, 2027

Conditions
Peripheral Neuropathy Due to ChemotherapyPeripheral NeuropathyNeurotoxicity SyndromesNeuropathy
Interventions
DIAGNOSTIC_TEST

Threshold Tracking Nerve Conduction Studies

Measurement of nerve excitability parameters, including response to sub-threshold pre-pulses and other stimuli. The DS5 0 Isolated Bipolar Constant Current Stimulator is a non-invasive, non-therapeutic device that provides controlled electrical stimuli for detailed function assessment of the superficial radial, superficial peroneal, ulnar, and sural nerves.

Trial Locations (2)

02215

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

lead

Ka-Wai Ho

OTHER

NCT07095998 - Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy | Biotech Hunter | Biotech Hunter